loading
Precedente Chiudi:
$2.53
Aprire:
$2.52
Volume 24 ore:
247.87K
Relative Volume:
0.18
Capitalizzazione di mercato:
$564.87M
Reddito:
-
Utile/perdita netta:
$-283.26M
Rapporto P/E:
-1.2672
EPS:
-1.89
Flusso di cassa netto:
$-273.61M
1 W Prestazione:
-6.37%
1M Prestazione:
-38.30%
6M Prestazione:
-70.78%
1 anno Prestazione:
-39.53%
Intervallo 1D:
Value
$2.38
$2.60
Intervallo di 1 settimana:
Value
$2.29
$2.65
Portata 52W:
Value
$2.29
$12.00

Sana Biotechnology Inc Stock (SANA) Company Profile

Name
Nome
Sana Biotechnology Inc
Name
Telefono
(206) 701-7914
Name
Indirizzo
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Name
Dipendente
328
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
SANA's Discussions on Twitter

Confronta SANA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
SANA 2.39 564.87M 0 -283.26M -273.61M -1.89
VRTX 447.21 115.74B 10.63B -479.80M -1.35B 13.33
REGN 737.75 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 586.52 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.92 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.55 24.49B 3.30B -501.07M 1.03B 11.54

Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-01-16 Aggiornamento H.C. Wainwright Neutral → Buy
2023-09-25 Iniziato JMP Securities Mkt Outperform
2023-09-05 Iniziato Citigroup Buy
2023-08-14 Iniziato TD Cowen Market Perform
2023-05-02 Iniziato H.C. Wainwright Neutral
2021-03-01 Iniziato BofA Securities Buy
2021-03-01 Iniziato Goldman Neutral
2021-03-01 Iniziato JP Morgan Neutral
2021-03-01 Iniziato Morgan Stanley Overweight
Mostra tutto

Sana Biotechnology Inc Borsa (SANA) Ultime notizie

pulisher
Nov 20, 2024

Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies - Quantisnow

Nov 20, 2024
pulisher
Nov 19, 2024

Sana Biotechnology: The Story Becomes Murkier (NASDAQ:SANA) - Seeking Alpha

Nov 19, 2024
pulisher
Nov 18, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc.SANA - PR Newswire

Nov 18, 2024
pulisher
Nov 18, 2024

Sana Biotechnology (NASDAQ:SANA) Reaches New 1-Year LowHere's Why - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Layoff Tracker: Adaptimmune Downsizes by 33% in Strategic Realignment - BioSpace

Nov 18, 2024
pulisher
Nov 13, 2024

10 Stocks Jeff Bezos Is Buying | Investing - U.S News & World Report Money

Nov 13, 2024
pulisher
Nov 13, 2024

Sana Biotechnology's SWOT analysis: stock outlook amid strategic pivot - Investing.com India

Nov 13, 2024
pulisher
Nov 13, 2024

Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio - Quantisnow

Nov 13, 2024
pulisher
Nov 13, 2024

Sana Biotechnology, Inc. (NASDAQ:SANA) Holdings Lowered by Baillie Gifford & Co. - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Sana Biotechnology stock hits 52-week low at $2.75 By Investing.com - Investing.com Australia

Nov 13, 2024
pulisher
Nov 12, 2024

FMR LLC's Strategic Acquisition of Sana Biotechnology Inc Shares - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

Sana Biotechnology stock hits 52-week low at $2.75 - Investing.com India

Nov 12, 2024
pulisher
Nov 12, 2024

Sana Biotech sustains stock target with Buy rating on Q3 earnings - Investing.com Nigeria

Nov 12, 2024
pulisher
Nov 12, 2024

Analyst keeps Buy on Sana Biotechnology, adjusts outlook as blood cancer competition rises - Investing.com Canada

Nov 12, 2024
pulisher
Nov 12, 2024

Sana Biotechnology's SWOT analysis: stock outlook amid strategic pivot By Investing.com - Investing.com Canada

Nov 12, 2024
pulisher
Nov 11, 2024

Sana Biotechnology (NASDAQ:SANA) Hits New 1-Year LowWhat's Next? - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Sana Biotechnology Inc Still Hasn’t Convinced Analysts? - Stocks Register

Nov 11, 2024
pulisher
Nov 11, 2024

HC Wainwright Reaffirms "Buy" Rating for Sana Biotechnology (NASDAQ:SANA) - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

Sana Biotechnology downgraded to Market Perform from Outperform at JMP Securities - MSN

Nov 09, 2024
pulisher
Nov 08, 2024

Sana Biotechnology, Inc. Reports Q3 2024 Financial Results - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Sana: Q3 Earnings Snapshot - The Washington Post

Nov 08, 2024
pulisher
Nov 08, 2024

Sana Biotechnology Inc. (SANA) Quarterly 10-Q Report - Quartzy

Nov 08, 2024
pulisher
Nov 08, 2024

Earnings Flash (SANA) SANA BIOTECHNOLOGY Reports Q3 Loss $-0.27 Per Share - Marketscreener.com

Nov 08, 2024
pulisher
Nov 08, 2024

Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates - The Manila Times

Nov 08, 2024
pulisher
Nov 08, 2024

HC Wainwright Issues Positive Estimate for SANA Earnings - Defense World

Nov 08, 2024
pulisher
Nov 07, 2024

HC Wainwright Issues Optimistic Forecast for SANA Earnings - MarketBeat

Nov 07, 2024
pulisher
Nov 05, 2024

Sana Biotechnology refocuses on autoimmune and diabetes therapies By Investing.com - Investing.com Australia

Nov 05, 2024
pulisher
Nov 05, 2024

Sana lowered to market perform by JMP over data uncertainty - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Sana Biotechnology (NASDAQ:SANA) Hits New 52-Week Low on Analyst Downgrade - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Sana Biotechnology (NASDAQ:SANA) Price Target Lowered to $8.00 at HC Wainwright - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Sana Biotechnology stock hits 52-week low at $3.05 - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

Sana to lay off staff, deepen autoimmune focus in latest retrenchment - BioPharma Dive

Nov 05, 2024
pulisher
Nov 05, 2024

500: Something went wrong - Investing.com UK

Nov 05, 2024
pulisher
Nov 05, 2024

Sana Biotechnology stock hits 52-week low at $3.05 By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

JMP Securities Downgrades Sana Biotechnology (NASDAQ:SANA) to Market Perform - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition of Sana Biotechnology Inc Shares - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

Sana Biotechnology refocuses on autoimmune and diabetes therapies - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Sana Biotechnology Announces Increased Focus on Type 1 - GlobeNewswire

Nov 04, 2024
pulisher
Oct 29, 2024

Sana Biotechnology (NASDAQ:SANA) Stock Price Down 6.6%Here's Why - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

Sana Biotechnology (NASDAQ:SANA) Shares Up 7.7%Still a Buy? - MarketBeat

Oct 28, 2024
pulisher
Oct 21, 2024

Sana Biotechnology (NASDAQ:SANA) Stock Price Down 6.4%What's Next? - MarketBeat

Oct 21, 2024
pulisher
Oct 21, 2024

Critical Comparison: Sana Biotechnology (NASDAQ:SANA) & SAB Biotherapeutics (NASDAQ:SABS) - Defense World

Oct 21, 2024
pulisher
Oct 18, 2024

Is Sana Biotechnology (NASDAQ:SANA) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Oct 18, 2024
pulisher
Oct 16, 2024

Why Sana Biotechnology, Inc. (SANA) is the Penny Stock with the Biggest Upside Potential According to Analysts - Insider Monkey

Oct 16, 2024
pulisher
Oct 16, 2024

Biotech stock tumbles after unexplained 1,446% gain - MSN

Oct 16, 2024
pulisher
Oct 15, 2024

Sana Biotechnology Inc (SANA) looking to reclaim success with recent performance - SETE News

Oct 15, 2024
pulisher
Oct 14, 2024

Sana Biotechnology Inc [SANA] Stock sold by Insider Mulligan Richard for $0.61 million - Knox Daily

Oct 14, 2024
pulisher
Oct 14, 2024

Market Insights: Sana Biotechnology Inc (SANA)’s Notable Gain of 4.18, Closing at 3.99 - The Dwinnex

Oct 14, 2024
pulisher
Oct 14, 2024

Sana Biotechnology Inc (SANA)’s stock price in review: A technical analysis - US Post News

Oct 14, 2024
pulisher
Oct 13, 2024

Sana Biotechnology, Inc. (SANA): Jeff Bezos Is Buying This Stock Now - Insider Monkey

Oct 13, 2024

Sana Biotechnology Inc Azioni (SANA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Sana Biotechnology Inc Azioni (SANA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Mulligan Richard
Director
Sep 24 '24
Sale
4.08
150,000
612,570
2,848,121
Mulligan Richard
Director
Sep 25 '24
Sale
3.89
150,000
583,170
2,698,121
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):